Apolipoprotein A-I Modulates Atherosclerosis Through Lymphatic Vessel-Dependent Mechanisms in Mice.

ABSTRACT: Subcutaneously injected lipid-free apoA-I (apolipoprotein A-I) reduces accumulation of lipid and immune cells within the aortic root of hypercholesterolemic mice without increasing high-density lipoprotein-cholesterol concentrations. Lymphatic vessels are now recognized as prerequisite players in the modulation of cholesterol removal from the artery wall in experimental conditions of plaque regression, and particular attention has been brought to the role of the collecting lymphatic vessels in early atherosclerosis-related lymphatic dysfunction. In the present study, we address whether and how preservation of collecting lymphatic function contributes to the protective effect of apoA-I. Atherosclerotic Ldlr-/- mice treated with low-dose lipid-free apoA-I showed enhanced lymphatic transport

SUBMITTER: Milasan A 

PROVIDER: S-EPMC5634311 | biostudies-literature | 2017 Sep

REPOSITORIES: biostudies-literature